Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
View Patent ↗The present invention provides compositions and methods for lowering plasma Lp(a) levels in humans. The present invention provides compositions and methods for lowering the risk factors for cardiovascular diseases. Moreover, this invention provides therapeutic alternatives to current pharmaceutical interventions for the lowering of cholesterol, LDL-cholesterol, triglycerides and other metabolic risk factors.
1. A method of lowering plasma concentration of a lipoprotein Lp(a) in a mammal, comprising administering to the mammal a composition of biochemical substances consisting essentially of ascorbic acid, ascorbyl palmitate, beta-, gamma-, delta-tocopherol-mix, beta-carotene, biotin, calcium ascorbate, calcium glycinate, α-carotene, lutein, zea-cryptoxanthin, cholecalciferol, chromium glycinate, citrus bioflavonoids, coenzyme Q 10, copper glycinate, cyanocobalamin, d-alpha-tocopherol, d-calcium pantothenate, dicalcium phosphate, folic acid, inositol, L-arginine, L-carnitine, L-cysteine, L-lysine, L-proline, L-seleonmethionine, magnesium ascorbate, magnesium glycinate, manganese chelate, molybdenum glycinate, niacin, niacinamide, potassium chelate, pycnogenol, pyridoxine, riboflavin, thiamine, and zinc glycinate, wherein the composition is in therapeutically effective amounts to lower the plasma concentration of the lipoprotein Lp(a) in a mammal.
2. The method according to claim 1 , wherein the mammal is a human.
3. The method according to claims 1 or 2 , wherein the plasma concentration of the lipoprotein is lowered by at least 4%.
4. The method according to claims 1 or 2 , wherein the plasma concentration of the lipoprotein is lowered by at least 8%.
5. The method according to claims 1 or 2 , wherein the plasma concentration of the lipoprotein is lowered by at least 12%.
6. The method according to claim 1 , wherein ascorbic acid is 1,580 mg, niacin is 60 mg, lysine is 110 mg, and proline is 110 mg.